article thumbnail

Enterprise Partners Portfolio Firm Heads To Market

socalTECH

One of the portfolio firms of San Diego-based venture capital firm Enterprise Partners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. Enterprise Partners owns about 14.8 According to a filing from Complete Genomics, it will sell 6 million shares at $9.00

article thumbnail

TargeGen Acquired By Sanofi-aventis

socalTECH

According to TargeGen, the deal's purchase price depends on the achievement of certain future milestones events. Tags: targegen sanofi aventis merger acquisition lifescience bioscience. TargeGen's products are also potentially useful in treating certain forms of leukemia, lymphoma, other hematological malignancies and blood disorders.